| WKN: | 789617 |
| ISIN: | US09062X1037 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Biogen-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 08. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 1999 | 6,04 | 29,48 | 388,08% |
| 2 | 2000 | 29,48 | 68,16 | 131,21% |
| 3 | 2013 | 102,13 | 186,94 | 83,04% |
| 4 | 2011 | 45,73 | 78,21 | 71,03% |
| 5 | 2004 | 27,17 | 45,50 | 67,46% |
| 6 | 2014 | 186,94 | 260,67 | 39,44% |
| 7 | 2010 | 33,98 | 45,73 | 34,58% |
| 8 | 2012 | 78,21 | 102,13 | 30,58% |
| 9 | 1998 | 4,91 | 6,04 | 23,01% |
| 10 | 2022 | 217,60 | 256,90 | 18,06% |
| 11 | 2009 | 30,61 | 33,98 | 11,01% |
| 12 | 2021 | 198,86 | 217,60 | 9,42% |
| 13 | 2001 | 68,16 | 72,49 | 6,35% |
| 14 | 2017 | 250,94 | 266,15 | 6,06% |
| 15 | 2007 | 34,32 | 36,38 | 6,00% |
| 16 | 2026 | 150,05 | 157,55 | 5,00% |
| 17 | 2025 | 143,85 | 150,05 | 4,31% |
| 18 | 2019 | 256,14 | 266,90 | 4,20% |
| 19 | 2015 | 260,67 | 259,70 | -0,37% |
| 20 | 2006 | 34,59 | 34,32 | -0,78% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2002 | 72,49 | 29,29 | -59,59% |
| 2 | 2024 | 234,40 | 143,85 | -38,63% |
| 3 | 2020 | 266,90 | 198,86 | -25,49% |
| 4 | 2005 | 45,50 | 34,59 | -23,98% |
| 5 | 2008 | 36,38 | 30,61 | -15,86% |
| 6 | 2023 | 256,90 | 234,40 | -8,76% |
| 7 | 2003 | 29,29 | 27,17 | -7,24% |
| 8 | 2018 | 266,15 | 256,14 | -3,76% |
| 9 | 2016 | 259,70 | 250,94 | -3,37% |
| 10 | 2006 | 34,59 | 34,32 | -0,78% |
| 11 | 2015 | 260,67 | 259,70 | -0,37% |
| 12 | 2019 | 256,14 | 266,90 | 4,20% |
| 13 | 2025 | 143,85 | 150,05 | 4,31% |
| 14 | 2026 | 150,05 | 157,55 | 5,00% |
| 15 | 2007 | 34,32 | 36,38 | 6,00% |
| 16 | 2017 | 250,94 | 266,15 | 6,06% |
| 17 | 2001 | 68,16 | 72,49 | 6,35% |
| 18 | 2021 | 198,86 | 217,60 | 9,42% |
| 19 | 2009 | 30,61 | 33,98 | 11,01% |
| 20 | 2022 | 217,60 | 256,90 | 18,06% |